David Perez is president and chief executive officer of Terumo BCT and serves as chairman of Terumo Corporation's Blood Management Division.

Perez is responsible for leading the strategic direction, growth and execution of Terumo BCT, with revenues approaching $1 billion. Under his leadership direction, the company delivers robust technology, innovation and core competencies to serve customers and their patients, who are the ultimate beneficiaries of the lifesaving gift of blood.

A dedicated and active industry leader with more than 30 years of experience within the medical device and healthcare industries, Perez also lends his expertise to numerous boards and councils. He serves the Advanced Medical Technology Association (AdvaMed) as treasurer, and as a member of the board of directors and executive committee, as well as the Technology and Regulation Committee. Perez is also chair of the board of trustees for the National Blood Foundation (NBF); a member of the NBF Council on Research and Development; treasurer of the Medical Device Innovation Consortium; and a board member of the Fitzsimons Redevelopment Authority for the Colorado life sciences community.

Prior to joining the Terumo BCT organization in 1999, Perez held leadership positions at UroTherapies Inc., Haemonetics® Corp., Caremark LLC, Coram Healthcare Corp. and Kendall. He earned his bachelor's degree in political science from Texas Tech University.